SavedAdd your journal

Journals / Kastamonu Üniversitesi Sağlık Bilimleri Fakültesi Dergisi / 2023 / Cilt: 2 Sayı: 3

Carbamazepine-Induced Facial Rash: A Case Report

Karbamazepine Bağlı Yüz Bölgesinde Döküntü: Bir Olgu Sunumu

Mehmet Hamdi Örüm(Elazığ Ruh Sağlığı ve Hastalıkları Hastanesi, Elazığ, Türkiye)0000-0002-4154-0738
Dilek Örüm(SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, ELAZIĞ FETHİ SEKİN ŞEHİR SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ)0000-0001-8369-1553
Pages
162–165
Publication Date
2023-12-31
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Clinicians should be alert to the rash side effect of carbamazepine.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Carbamazepine, which is used in the treatment of various neurological and psychiatric disorders, especially epilepsy, trigeminal neuralgia, bipolar disorder, and psychiatric symptoms such as aggression, can cause skin rash.
📊
Key Findings & Data:A 41-year-old male patient who presented with cocaine withdrawal and was started on 400 mg/day carbamazepine for impulse control developed a skin rash limited to the facial area on the tenth day of treatment.
💡
Conclusion & Impact:Clinicians should be alert to the rash side effect of carbamazepine.
🔬Design:Olgu Sunumu
📍Scope:Comprehensive Sample
⚙️Variables:Karbamazepin · yan etkiler · ilaç erüpsiyonu

Abstract

Carbamazepine, which is used in the treatment of various neurological and psychiatric disorders, especially epilepsy, trigeminal neuralgia, bipolar disorder, and psychiatric symptoms such as aggression, can cause skin rash. Here, we aimed to present a case of skin rash associated with carbamazepine. A 41-year-old male patient who presented with cocaine withdrawal and was started on 400 mg/day carbamazepine for impulse control developed a skin rash limited to the facial area on the tenth day of treatment. Based on the history, the existing side effect was associated with the use of carbamazepine and the drug was discontinued. Following discontinuation of carbamazepine, the skin rash gradually decreased and completely disappeared after twenty-three days. The patient's cocaine-related treatment was completed and he was discharged. No skin rash was observed in the follow-ups. Skin-related side effects may be related to carbamazepine use. Clinicians should be alert to the rash side effect of carbamazepine.

Özet

Epilepsi, trigeminal nevralji, bipolar bozukluk başta olmak üzere çeşitli nörolojik ve psikiyatrik bozuklukların ve saldırganlık gibi psikiyatrik belirtilerin tedavisinde kullanılan karbamazepin, deri döküntüsüne neden olabilir. Burada, karbamazepin ile ilişkili deri döküntüsü gelişen olguyu sunmayı amaçladık. Kokain yoksunluğu ile başvuran ve dürtü kontrolünü sağlamak amacıyla 400 mg/gün karbamazepin başlanan 41 yaşındaki erkek hastada tedavinin onuncu gününde yüz bölgesiyle sınırlı deri döküntüsü ortaya çıktı. Öyküden yola çıkılarak mevcut yan etki karbamazepin kullanımı ile ilişkilendirildi ve ilaç kesildi. Karbamazepin kesilmesini takiben deri döküntüsü giderek azaldı ve yirmi üç günün sonunda tamamen ortadan kayboldu. Hastanın kokain ile ilişkili tedavisi tamamlandı ve taburcu edildi. Takiplerinde deri döküntüsü gözlenmedi. Deri ile ilişkili yan etkiler karbamazepin kullanımı ile ilişkili olabilir. Klinisyenler, karbamazepinin deri döküntüsü yan etkisine karşı uyanık olmalıdır.

🔖

Cite This Article

Örüm, M. H., Örüm, D. (2023). Carbamazepine-Induced Facial Rash: A Case Report. Kastamonu Üniversitesi Sağlık Bilimleri Fakültesi Dergisi, Cilt: 2 Sayı: 3, 162–165. https://doi.org/10.59778/sbfdergisi.1300159

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Balato, N., Di Costanzo, L., Balato, A. (2009). Differential diagnosis of psoriasis. J Rheumatol Suppl, 83, 24-25. Edwards, I.R., Biriell, C. (1994). Harmonisation in pharmacovigilance. Drug Saf, 10, 93-102.
  2. Felthous, A.R., McCoy, B., Nassif, J.B., Duggirala, R., Kim, E., Carabellese, F., et al. (2021). Pharmacotherapy of Primary Impulsive Aggression in Violent Criminal Offenders. Front Psychol, 12, 744061.,
  3. Johnson, S.M., Berg, A., Barr, C. (2019). Recognizing rosacea: Tips on differential diagnosis. J Drugs Dermatol, 18(9), 888-894.
  4. Kose, S., Akin, E., Cetin, M. (2017). Adverse drug reactions and causality: The Turkish version of naranjo adverse drug reactions probability scale. Psychiatr Clin Psychopharmacol, 27(2), 205-206.
  5. Lallas, A., Argenziano, G., Apalla, Z., Gourhant, J.Y., Zaballos, P., Di Lernia, V., et al. (2014). Dermoscopic patterns of common facial inflammatory skin diseases. J Eur Acad Dermatol Venereol, 28(5), 609-614.
  6. Locharernkul, C., Shotelersuk, V., Hirankarn, N. (2011). Pharmacogenetic screening of carbamazepine-induced severe cutaneous allergic reactions. J Clin Neurosci, 18(10), 1289-1294.
  7. Mehta, M., Shah, J., Khakhkhar, T., Shah, R., Hemavathi, K.G. (2014). Anticonvulsant hypersensitivity syndrome associated with carbamazepine administration: Case series. J Pharmacol Pharmacother, 5(1), 59-62.
  8. Omairi, N.E.L., Abourazzak, S., Chaouki, S., Atmani, S., Hida, M. (2014). Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) induced by carbamazepine: a case report and literature review. Pan Afr Med J, 18, 9.
  9. Sidoroff, A., Halevy, S., Bavinck, J.N., Vaillant, L., Roujeau, J.C. (2001). Acute generalized exanthematous pustulosis (AGEP)--a clinical reaction pattern. J Cutan Pathol, 28(3), 113-9.
  10. Usatine, R.P., Riojas, M. (2010). Diagnosis and management of contact dermatitis. Am Fam Physician, 82(3), 249-255.